• S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)

  • 2024/01/29
  • 再生時間： 26 分
  • ポッドキャスト

S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode, Clinical Implications of Trophoblast-Cell Surface Antigen 2 in Non-Small Cell Lung Cancer, Dr. Justin Gainor and Dr. Helena Yu discusses the current diagnosis and treatment of non-small cell lung cancer as well as a new ADC target, trophoblast cell-surface antigen 2 or Trop2.

    Visit https://suiteweb.atpointofcare.com/#library/nsclc/2606.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
    続きを読む 一部表示

あらすじ・解説

In this episode, Clinical Implications of Trophoblast-Cell Surface Antigen 2 in Non-Small Cell Lung Cancer, Dr. Justin Gainor and Dr. Helena Yu discusses the current diagnosis and treatment of non-small cell lung cancer as well as a new ADC target, trophoblast cell-surface antigen 2 or Trop2.

Visit https://suiteweb.atpointofcare.com/#library/nsclc/2606.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
続きを読む 一部表示

S20:E1 – Clinical Implications of Trophoblast-Cell Surface Antigen 2 (TROP2) in Non-Small Cell Lung Cancer (NSCLC)に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。